Bill
HF 3609
Minnesota bill permanently bans drug manufacturers from restricting how healthcare providers distribute 340B-program discounted medications, with enforcement mechanisms added.
HF 3609 prohibits pharmaceutical manufacturers from restricting how covered entities (hospitals, clinics, and other healthcare providers) distribute drugs purchased through the federal 340B program, which provides discounted medications. The bill establishes enforcement mechanisms and removes the sunset clause, making these restrictions permanently illegal in Minnesota.
The 340B program allows safety-net providers to purchase drugs at steep discounts and reinvest savings into uncompensated care and services for vulnerable populations. Drug manufacturers have increasingly imposed "restrictions" (contract terms limiting where/how these discounted drugs can be used), effectively undermining the program's intent. This bill directly impacts drug pricing accessibility and healthcare provider operations across Minnesota.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
